Six global health threats to watch in 2026
A new Gavi insight paper highlights six immediate threats to global and regional health in 2026, and some of the initiatives, tools and solutions designed to keep them at bay.
Leaving no one behind with immunisation
Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate more than half the world’s children against some of the world's deadliest diseases.
Latest VaccinesWork features
View moreMajor study suggests transparent communication is key to vaccine uptake
A Lancet study of 1.1 million people suggests that most COVID-19 vaccine hesitancy reflected concrete concerns that faded over time, underscoring the importance of good information and transparent communication.
As mosquito populations grow, Nigeria confronts a swelling dengue threat
Often mistaken for malaria or other febrile illnesses, dengue may be flying under the radar – but cases are increasing across the country.
7 reasons why measles is more dangerous than you think
From hidden immune damage to delayed brain disease, measles carries risks that extend far beyond a childhood rash.
VaccinesWork is an award-winning digital platform hosted by Gavi, covering news, features and explainers from every corner of global health and immunisation.
Our work
Vaccine portfolio
Gavi supports vaccines against 20 infectious diseases, including Ebola, malaria, mpox and rabies.
Health systems support
Strong health and immunisation systems are vital to deliver vaccines to all the children who need them.
Civil society support
We provide grants for civil society organisations (CSOs) working to reach zero-dose children and missed communities with vaccines.
Shaping vaccine markets
Working to improve the health of markets for vaccines and other immunisation products.
The Gavi Leap
Transforming the Vaccine Alliance for the future through simplicity, transparency and synergy.
Latest Gavi news releases
View allPreventive cholera vaccination resumes as global supply reaches critical milestone
First preventive campaign in over three years launches in Mozambique, with others planned in Bangladesh and the Democratic Republic of the Congo.
Gavi announces new partnerships to accelerate innovation and expand access to immunisation
New private-sector and philanthropic partnerships will help Gavi scale innovation, strengthen healthcare and reach underserved communities.
Gavi CEO calls for global health leap
Gavi CEO Dr Sania Nishtar, writing in The Lancet, sets out a framework for radical reform of global health institutions.
The Vaccine Alliance
The Vaccine Alliance
Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.
Partner countries
Partner countries
Since its inception in 2000, Gavi has helped to immunise a whole generation – over 1.2 billion children – and prevented more than 20.6 million future deaths, helping to halve child mortality in 78 lower‑income countries.
Explore by region:
Africa | Americas | Eastern Mediterranean
Europe | South-East Asia | Western Pacific
Our donors
Our donors
As a public-private partnership, Gavi is funded by governments, foundations, institutions, organisations, corporations and private individuals.
